title: [Pregnancy in HIV infected women. Current therapeutic indications].
abstract: This paper deals with the management of pregnant women with HIV infection. The virus is transmitted by the mother to 20-30 percent of the infants, and therapeutic abortion should be offered to women whose pregnancy does not exceed 26 weeks of amenorrhoea. If pregnancy is pursued, the mother must be investigated for sexually transmitted diseases which are particularly frequent in this population and may have repercussions on the newborn. Pneumocystis carinii pneumonia is the most common opportunistic infection in pregnancy. In case of T4-cell depletion chemotherapy with pentamidine must be instituted. Hygienic and dietetic measures should be applied to avoid listeriosis and toxoplasmosis. Serological tests for toxoplasmosis are necessary in all HIV patients, with chemoprophylaxis in case of increased IgG levels. Thrombocytopenia usually responds to human immunoglobulins. At delivery, there is no need to modify the usual obstetrical procedures. During the post-partum period, another pregnancy must be avoided by good compliance with a reliable contraceptive method. As for the preventive treatment of mother-to-child HIV transmission, at the moment only AZT can be considered, but its effectiveness remains to be evaluated in therapeutic trials.
authors.affiliation: Service de Gynécologie-Obstétrique et Médecine de la Reproduction, Hôpital Saint-Roch, Nice.
authors.forename: J Y
authors.initials: JY
authors.lastname: Gillet
authors.forename: A
authors.initials: A
authors.lastname: Bongain
authors.forename: J G
authors.initials: JG
authors.lastname: Fuzibet
authors.forename: A
authors.initials: A
authors.lastname: Pesce
mesh_terms: D000032:Abortion, Therapeutic; D000328:Adult; D016860:CD4 Immunoadhesins / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D007116:Immunization, Passive; D007231:Infant, Newborn; D016898:Interferon-alpha / Q000627:therapeutic use; D008088:Listeriosis / Q000150:complications / Q000178:diet therapy; D009894:Opportunistic Infections / Q000150:complications / Q000628:therapy*; D010419:Pentamidine / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000188:drug therapy*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000628:therapy*; D013921:Thrombocytopenia / Q000209:etiology / Q000628:therapy; D014123:Toxoplasmosis / Q000150:complications / Q000178:diet therapy; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D016860:CD4 Immunoadhesins; D016898:Interferon-alpha; D015215:Zidovudine; D010419:Pentamidine
vernacular_title: Grossesse chez la femme infectée par le VIH. Indications thérapeutiques actuelles.